Tufts Medical Center Hematology and Medical Oncology

Topics

• Hematopoietic Stem Cell Transplantation 187
• Multiple Myeloma Research and Treatments 178
• Renal cell carcinoma treatment 166
• Lymphoma Diagnosis and Treatment 155
• Amyloidosis: Diagnosis, Treatment, Outcomes 137
• CAR-T cell therapy research 132
• Childhood Cancer Survivors' Quality of Life 107
• Chronic Lymphocytic Leukemia Research 107
• Cancer Immunotherapy and Biomarkers 97
• Acute Myeloid Leukemia Research 94
• Mesenchymal stem cell research 91
• Gastrointestinal Tumor Research and Treatment 82

Most cited

1. Sacituzumab Govitecan in Metastatic Triple-Negative Breast Cancer.

   The New England journal of medicine · 2021 · 1,378 citations · Kevin Kalinsky

2. Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 571 citations · Eric Jonasch

3. Datopotamab Deruxtecan Versus Chemotherapy in Previously Treated Inoperable/Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer: Primary Results From TROPION-Breast01.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 167 citations · Kevin Kalinsky

4. NCCN Guidelines® Insights: Head and Neck Cancers, Version 1.2022.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2022 · 456 citations · Panayiotis Savvides

5. Neuroendocrine and Adrenal Tumors, Version 2.2021, NCCN Clinical Practice Guidelines in Oncology.

   Journal of the National Comprehensive Cancer Network : JNCCN · 2021 · 538 citations · Lawrence Blaszkowsky

6. 21-Gene Assay to Inform Chemotherapy Benefit in Node-Positive Breast Cancer.

   The New England journal of medicine · 2021 · 751 citations ·